Literature DB >> 8197048

Cytomegalovirus colitis after 5-fluorouracil and interferon-alpha therapy.

J L Baker1, M P Gosland, J D Herrington, K E Record.   

Abstract

Cytomegalovirus (CMV) infection is an opportunistic viral infection primarily affecting immunocompromised patients. Patients with inflammatory bowel disease have an increased risk for developing CMV infections of the gastrointestinal tract. While receiving continuous infusion of 5-fluorouracil and interferon-alpha, a 72-year-old woman with stage IV pancreatic carcinoma developed severe colitis with diarrhea that was refractory to conventional antidiarrheals. A biopsy specimen from the colon revealed CMV inclusions, which were confirmed by immunofluorescence. The patient was given ganciclovir 210 mg (5 mg/kg) every 12 hours for 14 days, and the diarrhea resolved after approximately 8 days of therapy. This is the first reported case of CMV colitis associated with combination 5-fluorouracil and interferon-alpha therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197048

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  2 in total

1.  Diffuse mucosal damage in the large intestine associated with Irinotecan (CPT-11).

Authors:  J P Duong Van Huyen; F Bloch; A Attar; D Levoir; C Kreft; T Molina; P Bruneval
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

2.  Cytomegalovirus colitis following azacitidine therapy.

Authors:  Rajal Khan; Pam Rudkin; Kuljit Grewal; Jennifer Leonard; Mowafak Hamodat; Jim Hutchinson; Peter Daley
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.